Status:
RECRUITING
Developing a Real-Time PCR Assay for Fusobacterium and Epidemiological Analysis of Tumor Patients
Lead Sponsor:
Zhujiang Hospital
Collaborating Sponsors:
National Natural Science Foundation of China
Conditions:
Fusobacterium Infections
Eligibility:
All Genders
Brief Summary
This study presents an academic approach to developing a fluorescence quantitative PCR detection method capable of accurately measuring the presence of Fusobacterium (specifically F. nucleatum, F. mor...
Detailed Description
Fusobacterium nucleatum, a gram-negative obligate anaerobic bacterium, is known to colonize the oral cavity and is implicated in various diseases affecting the oropharynx, gastrointestinal tract, card...
Eligibility Criteria
Inclusion
- The inclusion criteria for this study encompassed fecal specimens obtained from patients with a documented history of tumor, specifically those who received their primary or initial tumor diagnosis at our hospital.
- Inclusion criteria for the control group consisted of the following: (1) Individuals who were in good health, devoid of evident diseases, and possessed normal physical examination reports; (2) Individuals who had not experienced significant chronic illnesses, such as hypertension, diabetes, chronic kidney disease, etc., in recent years, in order to exclude those who had been unwell but had normal physical examination reports; (3) Age and gender were matched with the case group.
Exclusion
- The exclusion criteria for this study include: A) Individuals who have taken an antimicrobial preparation within the past three months. B) Samples that lack complete information and cannot be traced back to their source. C) Samples with an insufficient volume for detection. D) Samples that do not meet the requirements for sample collection and preservation.
- \-
Key Trial Info
Start Date :
March 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
490 Patients enrolled
Trial Details
Trial ID
NCT06168513
Start Date
March 1 2023
End Date
December 31 2024
Last Update
April 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, China, 510000